Home › Funds › Rock Springs Capital Management LP › AMLX

Rock Springs Capital Management LP position in AMLX

AMYLYX PHARMACEUTICALS INC · Health Care

Rock Springs Capital Management LP reported holding 756,774 shares of AMLX (AMYLYX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$22.0M, representing 1.19% of its reported portfolio and ranking #21 among its reported holdings. Rock Springs Capital Management LP has disclosed AMLX holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)756.77K sh
Reported value held$22.02M
Portfolio Weight1.19%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Rock Springs Capital Management LP's AMLX position evolved

Rock Springs Capital Management LP first disclosed a stake in AMLX in Q3 2023 at 1,545,016 shares (US$28.3M). Across 10 filings, Rock Springs Capital Management LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 756,774 shares valued at US$22.0M — an increase of 257,010 shares quarter over quarter.. Notable position changes include a 65% trim in Q4 2023 (shares fell 81% over the following quarter), a 89% increase in Q1 2024 (shares fell 33% over the following quarter), a 51% increase in Q3 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.55M $28.29M New
Q4 2023 535.01K $7.88M Reduce
Q1 2024 1.01M $2.87M Add
Q1 2025 343.23K $1.22M New
Q2 2025 499.76K $3.20M Add
Q3 2025 499.76K $6.79M Hold
Q4 2025 499.76K $6.04M Hold
Q1 2026 499.76K $6.95M Hold
Q2 2026 499.76K $8.98M Hold
Q3 2026 756.77K $22.02M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMLX and 13F data

AMLX (AMYLYX PHARMACEUTICALS INC) is a Health Care company. 46 other funds we track also report a position in AMLX — the largest reported positions include TCG Crossover Management, LLC (US$181.7M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$158.0M), PERCEPTIVE ADVISORS LLC (US$149.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMLX

All AMLX fund holders →

FAQ

How long has Rock Springs Capital Management LP held AMLX?

Rock Springs Capital Management LP has disclosed AMLX holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

What is Rock Springs Capital Management LP's current position in AMLX?

As of Q3 2026, Rock Springs Capital Management LP holds 756.77K shares of AMLX (AMYLYX PHARMACEUTICALS INC), valued at $22.02M, representing 1.19% of its reported portfolio and ranking #21.

Has Rock Springs Capital Management LP been buying or selling AMLX?

In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP increased its position in AMLX.

Which other funds hold AMLX?

Other major institutional holders of AMLX include TCG Crossover Management, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.